Home/Filings/4/0001104659-24-007733
4//SEC Filing

Nolet Chris 4

Accession 0001104659-24-007733

CIK 0001868279other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 4:16 PM ET

Size

5.5 KB

Accession

0001104659-24-007733

Insider Transaction Report

Form 4
Period: 2024-01-25
Nolet Chris
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-25+17,88417,884 total
    Exercise: $18.00Exp: 2034-01-24Common Stock (17,884 underlying)
Footnotes (1)
  • [F1]These options vest on the first anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date.

Issuer

ArriVent Biopharma, Inc.

CIK 0001868279

Entity typeother

Related Parties

1
  • filerCIK 0001782814

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:16 PM ET
Size
5.5 KB